Angelman Syndrome clinical trials at University of California Health
2 in progress, 1 open to eligible people
Showing trials for
Angelman Syndrome Natural History Study
open to all eligible people
The goal of this study is to conduct a prospective, longitudinal natural history study of children and adults with Angelman Syndrome using investigator-observed and parent-reported outcome measures to obtain data that will be useful for future clinical trials.
at UCSD
REVEAL: A Phase 3 Study of Obudanersen (ION582) in Angelman Syndrome
Sorry, in progress, not accepting new patients
The purpose of this study is to evaluate the efficacy and safety of obudanersen in children and adults with Angelman syndrome caused by a deletion or mutation of the UBE3A gene.
at UCLA
Last updated: